Drugs / ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00474526 | Mar 2007 → Sep 2008 | meningococcal meningitis | Novartis Vaccines | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProQuad (Measles, Mumps, Rubella and Varicella vaccine) | “ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine)” NCT00474526 ↗ |
| Known as | MMR-V | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00474526 ↗ |
| Modality | Vaccine | “ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine)” NCT00474526 ↗ |